It has been reported that GSTO1 expression levels are significantly reduced in patients with cognitive impairment (Li et al., 2003), and a significant correlation between GSTO1 polymorphism and the age of AD onset has been found (Zhang et al., 2018). Here, GSTO1 is linked to Alzheimer disease.